BJP Email content delivery - eTOCs !
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Psychiatric Bulletin Advances in Psychiatric Treatment All RCPsych Journals
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ebstein, R. P.
Right arrow Articles by Kindler, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ebstein, R. P.
Right arrow Articles by Kindler, S.

The British Journal of Psychiatry 152: 665-669 (1988)
© 1988 The Royal College of Psychiatrists

Cyclic AMP second-messenger signal amplification in depression

RP Ebstein, B Lerer, B Shapira, Z Shemesh, DG Moscovich and S Kindler
Jerusalem Mental Health Center, Ezrath Nashim Hospital, Israel.

Beta-adrenergic-mediated cyclic AMP accumulation was reduced in lymphocytes obtained from depressed patients from that observed in an age- and sex-matched group of control subjects. Among the depressed patients, those not responding to treatment showed significantly lower pretreatment responses to isoproterenol compared with patients who exhibited significant clinical improvement during antidepressant treatment. Late-night (terminal) insomnia was significantly associated with the blunted response to beta-adrenergic stimulation. In depressed patients with the lowest isoproterenol response, the effect of forskolin (which acts distal to the receptor and directly stimulates the catalytic subunit) on cyclic AMP accumulation was also significantly decreased. This suggests that post-receptor modulations of signal amplification also play a role in the reduced response to beta-adrenergic stimulation in depression.


This article has been cited by other articles:


Home page
 Psychosom. Med.Home page
G. Chen, K. A. Hasanat, J. M. Bebchuk, G. J. Moore, D. Glitz, and H. K. Manji
Regulation of Signal Transduction Pathways and Gene Expression by Mood Stabilizers and Antidepressants
Psychosom Med, September 1, 1999; 61(5): 599 - 617.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. PsychiatryHome page
S. Avissar, Y. Nechamkin, G. Roitman, and G. Schreiber
Dynamics of ECT Normalization of Low G Protein Function and Immunoreactivity in Mononuclear Leukocytes of Patients With Major Depression
Am J Psychiatry, May 1, 1998; 155(5): 666 - 671.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Psychiatric Bulletin Advances in Psychiatric Treatment All RCPsych Journals
Copyright © 1988 The Royal College of Psychiatrists.